Lapointe Anthony Gregg is a director of Soligenix, Inc.
Person profile
Roles
Address
Gaithersburg, Maryland
Employees
Former names
Lapointe Gregg Anthony
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Astria Therapeutics, Inc.
6 Jun 24
4
RIGEL PHARMACEUTICALS INC
29 May 24
4
SOLIGENIX, INC.
15 Dec 23
4
RIGEL PHARMACEUTICALS INC
12 Jul 23
4
Astria Therapeutics, Inc.
6 Jun 23
4
SOLIGENIX, INC.
21 Nov 22
4/A
Astria Therapeutics, Inc.
21 Jun 22
4
Astria Therapeutics, Inc.
9 Jun 22
4
RIGEL PHARMACEUTICALS INC
23 May 22
4
SOLIGENIX, INC.
24 Sep 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
5 Jun 24 | ATXS Astria Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 9.18 | 14,100 | 129.44 k | 14,100 |
25 May 24 | RIGL Rigel Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 25,000 | 0.00 | 100,000 |
25 May 24 | RIGL Rigel Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 0.9075 | 30,000 | 27.23 k | 30,000 |
15 Dec 23 | SNGX Soligenix | Stock Option Common Stock | Grant | Acquire A | No | No | 0.59 | 38,136 | 22.50 k | 38,136 |
2 Jun 23 | ATXS Astria Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 11.35 | 14,100 | 160.04 k | 14,100 |
26 May 23 | RIGL Rigel Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 25,000 | 0.00 | 75,000 |
26 May 23 | RIGL Rigel Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 1.32 | 30,000 | 39.60 k | 30,000 |